NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

Boston Scientific Announces Acquisition of Obsidio, Inc.

by Ed Johnson
August 16, 2022
A A

Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio

MARLBOROUGH, Mass., — Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM™) technology used for embolization of blood vessels in the peripheral vasculature.

Embolization is a minimally invasive procedure intended to obstruct or reduce blood flow to an abnormality or tumor to stop hemorrhaging, reduce the size of malignant and benign tumors, and stabilize venous and arterial malformations.

Recently cleared by the U.S. Food and Drug Administration (FDA), the GEM technology is a semi-solid, proprietary material packaged in a ready-to-use form, thus reducing the preparation time required for many embolization procedures. Physicians deliver the GEM agent through a catheter, and its gel-like composition enables controlled placement within patient anatomy. Unlike solid and liquid embolics that can take time to form an obstruction to blood flow, once placed, the GEM technology conforms to the targeted vasculature, immediately creating a barrier. 

“The GEM technology combines benefits of currently available embolics, such as precise control of a solid and malleability of a liquid, to create a unique technology that offers procedural efficiency and a more personalized therapy for patients,” said Peter Pattison, president, interventional oncology and embolization, Peripheral Interventions, Boston Scientific. “This acquisition strengthens our interventional oncology and embolization portfolio with a differentiated solution for physicians and their patients suffering from hemorrhages, cancer and other debilitating conditions.”

The transaction is expected to be immaterial to Boston Scientific’s GAAP and adjusted earnings per share in 2022. Specific terms of the transaction have not been disclosed.

Tags: < Invest | M&A
ShareTweetShareSend

Related Industries

Healthcare

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

March 16, 2023
Healthcare

Medtronic named one of World’s Most Ethical Companies

March 14, 2023
Healthcare

Pfizer Invests $43 Billion to Battle Cancer

March 14, 2023
Healthcare

AskBio Announces Gustavo Pesquin as New CEO

March 10, 2023
Healthcare

Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.

March 9, 2023
Healthcare

Interview with Dr. Erik Walker, Board Chairman, Orlando Health Network

March 6, 2023

Walmart and CareSource Enter Agreement To Address Health Disparities

March 1, 2023

...

Hudson County Engages Honeywell To Help Develop And Implement A Smart Community Program

March 3, 2023

...

Inside Look: Introducing JD.com’s Newest Self-Operating Warehouse in California

March 3, 2023

...

Ford Establishes Latitude AI to Develop Future Automated Driving Technology

March 3, 2023

...

Medtronic named one of World’s Most Ethical Companies

March 14, 2023

...

Cargill, CUBIQ FOODS collaborate on novel fat technology to accelerate customer innovation of plant-based foods

March 2, 2023

...

The Estée Lauder Companies Appoints Lahnie Strange to Senior Vice President, Global General Manager, Bobbi Brown Cosmetics

March 4, 2023

...

USPS Selects Ford to Electrify Nation’s Largest Federal Fleet, Purchases 9,250 E-Transit Vans

March 2, 2023

...

North American Corporate Development & Strategy Awards 2022-2023

March 9, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.